東北證券(000686.SZ)獲准設立四家分支機構
格隆匯11月21日丨東北證券(000686.SZ)公佈,日前,公司收到中國證券監督管理委員會吉林監管局《關於核准東北證券股份有限公司設立四家分支機構的批覆》(吉證監許字〔2019〕11號)。根據該批覆,公司獲准在山東省煙台市設立一家分公司;在浙江省義烏市、浙江省杭州市蕭山區、廣東省廣州市各設立一家證券營業部。上述四家新設分支機構信息系統建設模式均為C型,業務範圍包括:證券經紀;證券投資諮詢;證券承銷與保薦(證監會禁止分支機構從事的除外);與證券交易、證券投資活動有關的財務顧問;融資融券;證券投資基金代銷;代銷金融產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.